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Abstract Many G protein-coupled receptor (GPCR) models
have been built over the years. The release of the structure of
bovine rhodopsin in August 2000 enabled us to analyze models
built before that period to learn more about the models we build
today. We conclude that the GPCR modelling ¢eld is riddled
with ‘common knowledge’ similar to Lord Kelvin’s remark in
1895 that ‘‘heavier-than-air £ying machines are impossible’’,
and we summarize what we think are the (im)possibilities of
modelling GPCRs using the coordinates of bovine rhodopsin
as a template. Associated WWW pages: http://www.gpcr.org/
articles/2003_mod/.
5 2004 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
G protein-coupled receptors (GPCRs) are the most impor-
tant target for the pharmaceutical industry, as is indicated by
the fact that 52% of all medicines available today act on them
[1]. About 5500 GPCR sequences are publicly available. The
GPCRDB [2] gives access to more than 10 000 mutations [3].
Binding constants are available for approximately 30 000
ligand^receptor combinations [2]. This wealth of sequences,
ligands, and mutations contrasts sharply with the small
amount of structural information.
Nearly all medicines are discovered by trial and error.
Nevertheless, most pharmaceutical companies have large re-
search departments that use every thinkable technique to de-
sign drugs. Homology modelling, as a tool to obtain structur-
al information, is one of those techniques. In the past,
bacteriorhodopsin [4^7] was often used as a modelling tem-
plate, but recently the three-dimensional coordinates [8] of
bovine rhodopsin have become available. It is a much better
template for GPCR homology modelling than bacteriorho-
dopsin. However, bovine rhodopsin is not yet the perfect
template, as will become clear later on in this article. Models
produced Before the Crystal structure became available are
called BC models, and those produced After these Data be-
came available are called AD models.
1.1. BC modelling
Most BC models were based on either bacteriorhodopsin
[4^7] or the CK coordinates of bovine rhodopsin derived by J.
Baldwin [9] from an electron di¡raction map [10^13]. A few
models [14^16] were based on ¢rst principles, sometimes
guided by a low-resolution electron di¡raction map [10,13]
of bovine or frog rhodopsin.
The BC modelling community developed a series of dog-
mas. E.g., a helix could not continue beyond the membrane
region; loops were not supposed to dock between the helices;
few models had helix kinks incorporated; Z-helices and other
irregularities were never considered; GPCRs had seven helices
spanning the membrane; short loops had either no regular
structure or the same structure as the isolated peptide in so-
lution; the lysine in helix VII that binds the retinal is the same
in bacteriorhodopsin and bovine rhodopsin. Generally the
dogmatic BC model recipe was:
1. Determine which template to use, or design your own he-
lix-packing model;
2. Use threading or moment calculations to determine the
mapping of the GPCR sequence onto the selected template.
Moment calculations can be based on hydrophobic mo-
ments [17], conservation moments [18], etc., or a combina-
tion of these [19]. Threading can be based on general rules,
helix bundle rules [19,20], or even bacteriorhodopsin-spe-
ci¢c rules [21] ;
3. Find experimental data that agree with the model and add
them to convince yourself or the referees that this is the
only correct model.
We found very many publications that discussed poor BC
models, showing that things that are lighter than air will £y
with referees and editors.
1.2. The bovine rhodopsin structure
The high-resolution structure of rhodopsin [8] reveals a
seven-helix bundle with a central cavity surrounded by helices
I^III and V^VII (see Fig. 1). Helix IV is not part of the cavity
wall and makes contacts only with helix III. The central cavity
is accessible from the cytosol, but the hairpin between helices
IV and V prevents access from the periplasm. This hairpin lies
between the helices, roughly parallel to the membrane surface.
It has contacts with side chains of most of the helices. The
most prominent contact is a disul¢de bridge to helix III.
2. Methods
Data too numerous and hypotheses too speculative to be
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put into print can be found at http://www.gpcr.org/articles/
2003_mod/ [22]. This website also contains a detailed recipe
for building models.
Bovine rhodopsin (PDBid= 1F88 [8]) and bacteriorhodop-
sin [4^6] are su⁄ciently di¡erently organized to make any
detailed structural comparison meaningless [10^12]. However,
in order to evaluate the quality of models based on the bac-
teriorhodopsin template, this superposition must be made. We
therefore did this structure superposition by hand. The recipe
for determining the quality of bacteriorhodopsin-based BC
models is as follows:
1. Extract from the GPCRDB the alignment of the sequence
of the GPCR model with the sequence of bovine rhodop-
sin;
2. Use the superposed structures to align the bovine rhodop-
sin sequence onto the bacteriorhodopsin sequence;
3. Extract from the modelling article how the authors aligned
their GPCR with bacteriorhodopsin. (If this alignment is
not given, it can be extracted from a superposition of the
bacteriorhodopsin-based GPCR model on the real bacter-
iorhodopsin structure.) This produces the alignment used
for the modelling.
A comparison of the ‘optimal’ alignment with the alignment
Fig. 1. The helix bundle in bovine rhodopsin. CK trace of bovine
rhodopsin [8]. Retinal is shown in purple, helices II^III orange, VI^
VII green, IV light blue, I and V red. Left: Side view. Right: Top
view.
Fig. 2. Superposed bovine rhodopsin structure and model. The bo-
vine rhodopsin structure [8] in red superposed in the GPCRDB [2]
BC model built with WHAT IF [42], based on the CK coordinates
provided by J. Baldwin [9].
Fig. 3. Sequence alignment extracted from deposited GPCR models produced by Cronet et al. [21], Oliveira et al. [44], Kuipers et al. [45,46],
and Rippmann and Bottcher [47]. The top two lines show the alignment of bovine rhodopsin with bacteriorhodopsin. The motifs containing
the most conserved residues in the GPCR transmembrane helices and the corresponding bacteriorhodopsin sequences are in red. The corre-
sponding residues in the four models are light green. The vertical bars indicate the most conserved residue in each helix. The numbers behind
these bars correspond to the GPCRDB [2] numbering schemes (the Cys in hairpin IV^V has number 480 in this numbering scheme). The num-
bers behind the sequences indicate the shift away from the perfect alignment. Minus signs indicate residues not available in the models. The
fact that we could publish models that had residues misaligned by as many as 10 positions holds a warning for the future. It is important to
realize that these alignments were (among) the best we could ¢nd in the literature that did not use the electron density-based CK coordinates
extracted from Schertler’s electron density map by Baldwin.
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used by the modeller is a good indication of the model qual-
ity. (This same method is used by the CASP competition
judges to evaluate threading results [23].) Our recipe for ob-
taining these BC model alignment shifts di¡ers, however, from
what is normally used because only the structure of bovine
rhodopsin is known, whilst the L3-adrenergic receptor is the
most-modelled GPCR.
3. Results and discussion
3.1. The quality of BC models
Fig. 2 shows the superposition of the structure [8] and a
very good BC model built, published [9], and deposited before
August 2000. It can be seen that the gross features are mod-
elled reasonably well. The CK and all-atom modelling errors
(i.e. displacements between the model and the X-ray structure)
are 2.5 AU and 3.2 AU , respectively. Although impressive, this
model is still too bad to be of any use for ‘rational drug
design’ purposes.
Bacteriorhodopsin and bovine rhodopsin are so di¡erent
that quantitative structure comparisons are meaningless. We
selected a superposition with a large overlap of the two retinal
molecules. A shift in the structure superposition leads to a
shift of three or four positions in the sequence alignment,
which alternates between positive and negative in the seven
helices. As can be seen from the alignments in Fig. 3, such a
shift does not improve the alignments. Therefore, the subjec-
tive nature of the superposition does not in£uence our con-
clusions. We believe that all GPCR models (including our
own) that are based on the bacteriorhodopsin template are
bad, and none can have made a positive contribution to ra-
tional drug design projects. A more extensive discussion of BC
models can be found in the article section of the GPCRDB
[2].
No BC model had the IV^V hairpin located correctly be-
tween the helices. All modellers ‘knew’ that loop IV^V was
external, but they were also aware of the disul¢de bridge
between helix III and this IV^V hairpin. Often bizarre reason-
ing was used to reconcile these two contradicting ‘facts’ and to
justify the position of helix III. The experimental data en-
abling the correct prediction of the IV^V hairpin location
were available to the BC modellers, because it was known
that in opsins His474 and Lys477 in this hairpin form a chlo-
ride binding site that regulates the optimal absorption wave-
length of the retinal [24]. It could have been reasoned that if
this site modi¢es the wavelength, it should be located near the
retinal. Unfortunately, the common ‘knowledge’ that the
loops stick out into the solvent overcame the experimental
data about the chloride site.
3.2. The quality of AD models
We were surprised to ¢nd many modelling studies per-
formed after the release of the bovine rhodopsin three-dimen-
sional coordinates into which very little knowledge of this
template was incorporated. Ballesteros et al. [25] recently
wrote that amine receptors can be modelled from the bovine
rhodopsin template. They neglect the IV^V hairpin, crystal
contacts, and the fact that many residues cannot be detected
in the X-ray structure. Orry et al. [26] docked endothelin in an
endothelin receptor model based on a rhodopsin model by
Pogozheva et al. [20]. They write in a note added after sub-
mission that the bovine rhodopsin structure became available
after the paper was ¢rst submitted, and claim that their model
and the bovine rhodopsin structure are similar. Their model is
not deposited, but from the ¢gures in the article, it can be seen
that the endothelin molecule is docked where one would ex-
pect the IV^V hairpin, and this hairpin is modelled as a hyper-
exposed loop. These are just two of the many examples of
neglect of details of the bovine rhodopsin structure. A survey
of recent, GPCR modelling-related literature revealed a series
of £aws:
1. Total neglect of loops and the IV^V hairpin [27^30] ;
2. Modelling loops based on data for individual loops ob-
tained from nuclear magnetic resonance experiments or
from sequence similarity with another PDB ¢le [31^34];
3. Models in which molecular dynamics compacted the IV^V
hairpin [35] ;
4. Models based on a frog CK map [36].
It is regrettable that a molecular dynamics publication on a
homology model can be accepted for publication when the
author has failed to show what the same protocol does to
the bovine rhodopsin structure. All GPCR models are wrong,
but some GPCR models can be useful [37]. Only the ¢rst part
of this modi¢cation of a famous quote of G.E.P. Box, how-
ever, applies to the majority of the recently published GPCR
models.
3.3. AD GPCR modelling
The availability of the bovine rhodopsin structure opens
new alleys for modelling GPCRs. However, some warnings
are needed. First, the observed structure of many loops seems
to be determined by crystal contacts. Second, the bovine rho-
dopsin structure is the inactive form of the protein, whilst the
active form is a much more appropriate modelling goal for
pharmaceutical purposes. Third, it is far from certain that the
bovine rhodopsin structure can be used as a template for all
GPCRs, because many sequence analyses indicate that opsins
di¡er very much from the pharmaceutically interesting (class
A) GPCRs. Fourth, the rhodopsin structure is an anti-parallel
dimer, whereas GPCR dimers must be parallel.
Modelling studies start with a sequence alignment between
the bovine rhodopsin template and the GPCR model se-
quence. The percentage sequence identity between bovine rho-
dopsin and many other (class A) GPCRs can be as low as
20%. Normally, when the sequence identity between the mod-
el and the template falls below 30%, the sequence alignment is
the main bottleneck in the homology modelling procedure.
Class A GPCRs are an exception to this rule, because each
helix contains one or two highly conserved residues that allow
an unambiguous alignment.
It is di⁄cult to model the loops by homology, because most
cytosolic loops cannot be seen in an electron density map, and
most observed extracellular loop structures are probably in-
duced by crystal packing forces. In any case, the sequence
identity between most GPCRs and bovine rhodopsin is too
low to derive any reliable loop alignment. At three locations,
however, features can be seen that give hope for modelling.
These are the highly conserved (details are provided in the
WWW pages; numbering as in Fig. 3):
1. Trp280 and Gly295 in loop II^III;
2. Loop IV^V and the Cys315^Cys480 disul¢de bridge;
3. Tyr734 at the bend between the helices VII and VIII and
the adjacent sequence motif Phe800, Arg/Lys801 in helix
VIII.
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3.4. The active form
Modelling the active form of AGPCRs depends critically on
the hypothesized mechanism of that activation process. We
therefore start with a summary of possible activation mecha-
nisms. These activation models consist of essentially the same
three general steps:
1. Entry of the ligand into the ligand binding pocket;
2. The receptor moving from the inactive state into the active
state, or the active state being frozen by the ligand;
3. The G protein being activated, or the activated state being
frozen.
The clearest lesson to be learned from the BC experience is
that molecular dynamics technology has not reached the level
of maturity needed to aid in the prediction of the di¡erences
between the active and the inactive state.
3.5. New rules to replace the old dogmas
For most studies, it will be enough to model the seven
transmembrane helices and the IV^V hairpin. If more loops
are needed in the model, there is some hope for a few recep-
tors that these loop models can be based on the structure, but
in most cases it will not be possible to model them. The work
by Yeagle et al. [38^41] makes clear that determination of the
structure of the loops independently of the rest of the mole-
cule is not successful.
The alignment of the helices should be based on the con-
served motifs. Extrapolating from the performance of GPCR
modellers over the years, we can only advise sticking to the
bovine rhodopsin helix backbone coordinates. Any attempt to
‘improve’ this for other GPCRs will undoubtedly make things
worse rather than better.
The IV^V hairpin should be modelled from bovine rhodop-
sin. If this loop is not present in the model sequence, it seems
doubtful that a reliable model structure can be built.
If data exist that indicate dimer formation, these data must
be used. Several studies, i.e. atomic force microscopy [43]
work on mouse rhodopsins, can provide good information
on how to model dimers, if needed.
The bovine rhodopsin three-dimensional coordinates repre-
sent the inactive form of this receptor. To model the (phar-
maceutically much more interesting) active form of GPCRs,
one should not rely on molecular dynamics, but rather on the
outcome of experiments that can be interpreted unambigu-
ously.
Our WWW pages list a recipe for modelling the active form
of a receptor. One day, this recipe will be proven wrong, but it
is the best we can do given current data and Occam’s razor.
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